ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Search through all presentations

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...2014/Translating-genetics-into-clinical-care

Body Abstract:Large-scale, world-wide efforts to catalog the genetic, epigenetic, and transcriptional changes that drive human cancers have dramatically increased the known inventory of genes and...

Date: 27 Sep 2014
Presenter: Thorsten Zenz
Resources: Abstract
Topics: Haematologic Malignancies, Personalised Medicine, Translational Research

http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Targeting-the-cyclins

Body Abstract:Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults in the western countries. The disease can be quite heterogeneous in terms of clinical behavior with a portion...

Date: 27 Sep 2014
Presenter: Paolo Ghia
Resources: Abstract, Presentation, Webcast
Topics: Drug Development, Haematologic Malignancies, Translational Research

http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Targeting-the-BCL-2-pathway

Body Abstract:Many, if not most, anti-cancer agents kill cancer cells via the mitochondrial pathway of apoptosis. We have investigated ways that we can predict whether a particular agent will active...

Date: 27 Sep 2014
Presenter: Anthony Letai
Resources: Abstract, Presentation, Webcast
Topics: Drug Development, Haematologic Malignancies, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...tients-with-multicentric-Castleman-s-disease

AimCastleman's disese (CD) is a rare polyclonal lymphoproliferative disease that presents a variety of symptoms and clinical courses. Multicentric Castleman's disese (MCD) is defined by the involvement...

Date: 28 Sep 2014
Presenter: Seyoung Seo
Resources: Abstract
Topic: Haematologic Malignancies

http://oncologypro.esmo.org/Meeting-Resourc...gous-hematopoietic-stem-cell-transplantation

AimObesity is an increasingly prevalent problem worldwide, even in patients undergoing hematopoietic stem cell transplantation (HSCT). In the setting of HSCT, obesity may contribute to poorer outcomes...

Date: 28 Sep 2014
Presenter: Sherilyn Tuazon
Resources: Abstract
Topics: Cancer Aetiology, Epidemiology, Prevention, Haematologic Malignancies, Surgery and/or Radiotherapy of Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ted-discussant-abstracts-947O-948O-and-LBA28

Date: 29 Sep 2014
Presenter: Faith Davies
Resources: Presentation, Webcast
Topic: Haematologic Malignancies

http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Haematological-malignancies2

Date: 30 Sep 2014
Presenter: Faith Davies
Resources: Presentation
Topics: Anti-Cancer Agents & Biologic Therapy, Haematologic Malignancies